Feb 21 / 2020
Latest News / Editorial/ Production

MediPharm to supply Medical Cannabis by Shopers

MediPharm Labs will supply medical cannabis products nationally in Canada through to Medical Cannabis by Shoppers

MediPharm Labs Corp., a global leader in specialised, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, announced Shoppers Drug Mart, Canada’s leading pharmacy retailer, has selected its wholly-owned subsidiary, MediPharm Labs Inc. (“MediPharm”), to supply high-quality cannabis concentrate products to medical patients nationally in Canada through its online platform Medical Cannabis by Shoppers.

Under the terms of the agreement, MediPharm will utilise its proprietary pharmaceutical manufacturing platform, methodologies and scientific data to provide Medical Cannabis by Shoppers with a wide range of concentrate-based products starting with formulated bottled oils. MediPharm will provide other derivative products such as gel caps and topicals as they become available. The agreement is for a three-year term subject to renewal for an additional two years. Formulated oils provided under the agreement are expected to begin being shipped to Shoppers within the first two months of the agreement.

Pat McCutcheon, MediPharm Labs CEO.

“MediPharm Labs is proud to be partnering with one of Canada’s most trusted names in retail to bring new and innovative pharmaceutical-quality cannabis concentrate products to Shoppers’ medical consumers across Canada,” said Pat McCutcheon, CEO, MediPharm Labs.  “With our pharmaceutically trained team, our GMP certified platform and research licence permitting human trials, MediPharm Labs has the ability to develop advanced cannabis products backed by proprietary scientific research that will serve as the foundation for further expansion of future offerings.”

Medical Cannabis by Shoppers launched in January 2019. The platform ships products from Canadian licensed producers directly and discreetly to customers in all provinces and territories in Canada. Under current regulations, pharmacists cannot dispense medical cannabis from a pharmacy.

According to Statistics Canada, approximately 1.1 million Canadians use cannabis for medical purposes. MediPharm Labs is pleased to partner with a retailer who is not only committed to providing patients with high-quality medical cannabis from a trusted source, but guidance from specialised advisors. Such guidance is important in ensuring patients achieve satisfaction with their customer experience.

About Medical Cannabiz World:

In November 2019, Medical Cannabiz World opened its doors to the medicinal cannabis industry, supported by the Maltese government’s commitment to legislation for this high growth sector.  Medical Cannabiz World summit 2020 will focus on the Malta medical cannabis industry as well as global opportunities in the sector, attracting investors, medical researchers, policy makers and entrepreneurs looking to forge exciting new opportunities.

Share this entry: gplus-button facebook-button linkedin-button twitter-button
or go back to NEWS page